Nemeth P R, Gullikson G W
Gastrointestinal Diseases Research, G.D. Searle & Co., Skokie, IL 60077.
Eur J Pharmacol. 1989 Aug 3;166(3):387-91. doi: 10.1016/0014-2999(89)90350-6.
5-HT3 receptor antagonists may have both antiemetic and gastric and intestinal motility stimulating properties, but they differ in their relative potencies and efficacies for these two activities. Since the 5-HT3 receptor is present on enteric neurons, intracellular recordings of myenteric neuronal transmembrane potential were used to assess the actions of four proposed motility stimulating drugs, metoclopramide, BRL 24924, ICS 205-930 and cisapride. BRL 24924 (10(-6) M), ICS 205-930 (10(-7) M) and cisapride (5 x 10(-6) M) each antagonized the 5-HT3-mediated fast depolarization of myenteric neurons. Metoclopramide (10(-5) M) was less consistent in its ability to antagonize this response, and the response often returned in the continued presence of metoclopramide. In the present study, BRL 24924 (10(-6) M) and, as previously shown, cisapride (5 x 10(-6) M) antagonized the slow depolarization of myenteric neurons induced by 5-HT. Metoclopramide (10(-5) M), BRL 24924 (10(-6) M) and cisapride (5 x 10(-6) M), but not ICS 205-930 (10(-7) M) depolarized myenteric neurons within the first 2 min of contact with myenteric neurons. These data support the view that there are separate receptors that may be responsible for the prokinetic actions of these drugs and a series of 5-HT3-mediated actions which include antiemesis.
5-羟色胺3(5-HT3)受体拮抗剂可能具有止吐以及刺激胃肠蠕动的特性,但它们在这两种活性的相对效力和功效方面存在差异。由于5-HT3受体存在于肠神经元上,因此采用肌间神经丛神经元跨膜电位的细胞内记录来评估四种拟议的促动力药物,即甲氧氯普胺、BRL 24924、ICS 205 - 930和西沙必利的作用。BRL 24924(10⁻⁶ M)、ICS 205 - 930(10⁻⁷ M)和西沙必利(5×10⁻⁶ M)均可拮抗5-HT3介导的肌间神经丛神经元快速去极化。甲氧氯普胺(10⁻⁵ M)拮抗这种反应的能力不太稳定,并且在甲氧氯普胺持续存在的情况下反应常常恢复。在本研究中,BRL 24924(10⁻⁶ M)以及如先前所示的西沙必利(5×10⁻⁶ M)可拮抗5-HT诱导的肌间神经丛神经元缓慢去极化。甲氧氯普胺(10⁻⁵ M)、BRL 24924(10⁻⁶ M)和西沙必利(5×10⁻⁶ M),但不包括ICS 205 - 930(10⁻⁷ M),在与肌间神经丛神经元接触后的最初2分钟内可使肌间神经丛神经元去极化。这些数据支持这样一种观点,即存在不同受体,它们可能分别负责这些药物的促动力作用以及一系列包括止吐作用在内的5-HT3介导的作用。